Panacea Index Logo

Command Palette

Search for a command to run...

Melatonin triggers autophagic cell death by regulating RORC in Hodgkin lymphoma.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
March 1, 2020
Gege Yan et al. (12 authors)
Journal ArticleMolecular Study
Extracted Claims (13)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Melatonin (Mel)
decrease
Hodgkin lymphoma (HL)
HL cells
-
exerted anti-tumor activities
#1
Melatonin (Mel)
decrease
cell proliferation
HL cells
-
inhibiting
#2
Melatonin (Mel)
increase
cell apoptosis
HL cells
-
promoting
#3
Melatonin (Mel) treatment
increase
expression of LC3-II
HL cells
-
increased
#4
Melatonin (Mel) treatment
decrease
p62 proteins
HL cells
-
decreased
#5
Melatonin (Mel) treatment
increase
production of autolysosome
HL cells
-
enhanced
#6
Melatonin (Mel) treatment
increase
autophagy
HL cells
-
induced activation of
#7
Melatonin (Mel) treatment together with autophagy inhibitors 3-MA or CQ
increase
damage effect of Mel
HL cells
-
exacerbated
#8
Melatonin (Mel) treatment
increase
expression of G protein-coupled receptors MT2
HL cells
-
increased
#9
Melatonin (Mel) treatment
increase
expression of retinoic acid-related orphan receptors (RORs)
HL cells
-
increased
#10
Melatonin (Mel) treatment
increase
RORC
HL cells
-
has the highest increase
#11
RORC overexpression
increase
autophagy activation
HL cells
-
induced
#12
Melatonin (Mel)
decrease
HL
HL cells
-
showed tumor-suppressive role
#13
Abstract

Melatonin (Mel) has been shown to involve in many essential cell functions via modulating many signaling pathways. We for the first time investigated that Mel exerted anti-tumor activities in Hodgkin lymphoma (HL) via inhibiting cell proliferation and promoting cell apoptosis. Further study revealed that Mel treatment increased expression of LC3-II and decreased p62 proteins with the enhanced production of autolysosome, indicating it induced activation of autophagy. Nevertheless, Mel treatment together with autophagy inhibitors 3-MA or CQ exacerbated the damage effect of Mel in HL cells, which means autophagy plays a protective role in this process. Furthermore, we found Mel treatment increased the expression of G protein-coupled receptors MT2 and retinoic acid-related orphan receptors (RORs), eg. RORA, RORB and RORC. While RORC has the highest increase in Mel treated HL cells. In addition, RORC overexpression induced autophagy activation. Therefore, Mel showed tumor-suppressive role due to an increased level of RORC induced autophagy in HL.

Medical Subject Headings (MeSH)
AdenineAntineoplastic AgentsApoptosisAutophagic Cell DeathCell Line, TumorCell SurvivalHodgkin DiseaseHumansMelatoninNuclear Receptor Subfamily 1, Group F, Member 3
Study Links
PubMed ID31924597
Related Supplements